CLDF Title
Home | Contact Us | Bookmark
Embassy of Education  
Live Events Slide Library Webcasts Abstract Library Committee Members


Beginning Date


Ending Date





Robert Gish, MD
Professor Consultant
Stanford University
Senior Medical Director
St. Joseph’s Hospital and Medical Center
Phoenix, Arizona

Steven Flamm, MD
Chief, Liver Transplantation
Professor of Medicine and Surgery
Feinberg School of Medicine, Northwestern University
Chicago, Illinois


Webcast must be viewed in its entirety to claim credit.

Accredited by:

This activity is provided by the Chronic Liver Disease Foundation and endorsed by IC-HEP United States.

This activity Supported by:

Bristol-Myers Squibb & Merck & Co.

Target Audience
This educational program will address the educational needs of health care professionals on the screening, diagnosis and management of patients with chronic liver disease.
Educational Objectives
At the conclusion of this activity, participants will be able to:
Apply AASLD/IDSA HCV treatment guidance recommendations in clinical practice
Describe baseline factors that impact treatment decisions with HCV direct-acting antiviral regimens
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest:
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF), have no relationships to disclose.

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the Annenberg Center for Health Sciences at Eisenhower. The information is presented for the purpose of advancing the attendees' professional development.
Learner Assurance Statement
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Additional Planners/Reviewers affiliation and disclosure statements
Robert Gish, MD
Advisor/Consultant: Abbott, AbbVie, Akshaya, Alexion, Arrowhead, Astra- Zeneca, Bayer AG, Bristol-Myers Squibb, Contravir, Eiger, Enyo, Genentech, Gilead Sciences, Hoffmann-LaRoche, Humabs, Intellia, Intercept, Ionis Pharmaceuticals, Janssen, MedImmune, Merck, Nanogen, Novira.
Speaker's Bureau: AbbVie, Alexion, Bayer, Bristol-Myers Squibb, Gilead Sciences, Merck, Salix/Valeant.
Received grants for clinical research from: AbbVie, Benitec, Gilead Sciences, Merck.
Stock, Stock Options, Bonds: Arrowhead, Kinex, Synageva, RiboSciences, CoCrystal.

Steven L. Flamm, MD
Speaker's Bureau: AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck.
Grants/Research Support: AbbVie, Bristol-Myers Squibb, Gilead Sciences.


Be the first to know about our latest upcoming programs and events!


Follow us

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2022 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.